---
title: Approaching a therapeutic inflection point for FLT3-mutated AML
date: '2024-11-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39541573/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241115181608&v=2.18.0.post9+e462414
source: Blood
description: Combining FLT3 inhibitors with intensive chemotherapy and transplant
  has substantially improved AML outcomes, prompting a recent re-evaluation of FLT3-ITD's
  historically negative prognostic effect. Treatment approaches may soon undergo major
  changes as emerging data suggest maximal intensity does not benefit all patients
  and MRD potentially can guide several treatment choices. Finally, recent data also
  suggest FLT3 inhibitors could transform outcomes in patients unsuitable for intensive
  ...
disable_comments: true
---
Combining FLT3 inhibitors with intensive chemotherapy and transplant has substantially improved AML outcomes, prompting a recent re-evaluation of FLT3-ITD's historically negative prognostic effect. Treatment approaches may soon undergo major changes as emerging data suggest maximal intensity does not benefit all patients and MRD potentially can guide several treatment choices. Finally, recent data also suggest FLT3 inhibitors could transform outcomes in patients unsuitable for intensive ...